| Product Unit Size | Cost | Quantity | Stock |
|---|
CAY10505 is an inhibitor of p110γ PI3K. CAY10505 increases endothelial relaxation, normalizes levels of glutathione, nitrate, and nitrite, and alters the vascular endothelial lining in hypertensive rats, improving vascular endothelial dysfunction.
| Cas No. | 1218777-13-9 |
|---|---|
| Purity | ≥98% |
| Formula | C14H8FNO3S |
| Formula Wt. | 289.28 |
| IUPAC Name | (5E)-5-[[5-(4-fluorophenyl)furan-2-yl]methylidene]-1,3-thiazolidine-2,4-dione |
| Solubility | DMSO 58 mg/mL (200.49 mM) Water Insoluble Ethanol Insoluble |
| Appearance | Orange Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Tyagi S, Sharma S, Budhiraja RD. Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats. Can J Physiol Pharmacol. 2012 Jul;90(7):881-5. PMID: 22731503.